financetom
Market
financetom
/
Market
/
US Futures Rise Pre-Bell as Investors Await Key Employment, Manufacturing Data
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US Futures Rise Pre-Bell as Investors Await Key Employment, Manufacturing Data
Nov 1, 2024 6:04 AM

08:11 AM EDT, 11/01/2024 (MT Newswires) -- US stock futures are moving higher in Friday's premarket activity as investors await key employment and manufacturing data set to be released later in the morning.

The Dow Jones Industrial Average futures were up 0.4%, S&P 500 futures gained 0.4%, and Nasdaq futures were rising 0.5%.

Oil prices were surging higher, with front-month global benchmarks Brent crude and West Texas Intermediate crude rising 2% and 2.2% respectively.

The unemployment rate for October is expected to remain unchanged at 4.1%, while nonfarm payrolls for the month are forecast to fall to 106,000 from 254,000 the previous month, according to Bloomberg.

Meanwhile, the Manufacturing Purchasing Managers' Index is expected to stay unchanged for October at 47.8 and remain below the 50-point threshold demarcating contraction from expansion, according to Bloomberg.

In equities, shares of Globalstar ( GSAT ) jumped 52% after the company said in a regulatory filing Friday that it has updated its service agreements with Apple (AAPL) to expand its mobile satellite services network. Theriva Biologics ( TOVX ) shares surged 43% after it said late Thursday that it has been named as one of five finalists for Merck's (MRK) Advance Biotech Grant. Shares of VS MEDIA ( VSME ) advanced 36% following an 11% loss the previous session.

On the losing side, shares of Essa Pharma ( EPIX ) plummeted nearly 70% after it said it is terminating a phase 2 trial evaluating the combination of masofaniten and enzalutamide in patients with metastatic castration-resistant prostate cancer compared with enzalutamide alone. Lexicon Pharmaceuticals ( LXRX ) shares plunged 38% after it said late Thursday that the US Food and Drug Administration denied its new-drug application for Zynquista to treat glycemic control in adults with type 1 diabetes and chronic kidney disease. The FDA said that the benefits of Zynquista do not outweigh the risks in adults. Shares of Advent Technologies ( ADN ) fell more than 15% after a 33% gain on Thursday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US STOCKS-S&P 500, Nasdaq set to open lower as tech valuation jitters resurface
US STOCKS-S&P 500, Nasdaq set to open lower as tech valuation jitters resurface
Nov 11, 2025
(For a Reuters live blog on U.S., UK and European stock markets, click or type LIVE/ in a news window.) * Futures: Dow up 0.05%, S&P 500 down 0.2%, Nasdaq down 0.5% * Paramount Skydance ( PSKY ) gains on cost-cut, investment plans * Japan's SoftBank offloads Nvidia ( NVDA ) shares * CoreWeave ( CRWV ) drops after trimming...
Exchange-Traded Funds Lower, Equity Futures Mixed Pre-Bell Tuesday as Investors Assess Impact of Government Shutdown
Exchange-Traded Funds Lower, Equity Futures Mixed Pre-Bell Tuesday as Investors Assess Impact of Government Shutdown
Nov 11, 2025
08:40 AM EST, 11/11/2025 (MT Newswires) -- The broad market exchange-traded fund SPDR S&P 500 ETF Trust ( SPY ) was down 0.3% and the actively traded Invesco QQQ Trust (QQQ) was 0.5% lower in Tuesday's premarket activity as investors still assess the impacts of the US government shutdown. US stock futures were mixed, with S&P 500 Index futures down...
Sector Update: Tech
Sector Update: Tech
Nov 11, 2025
08:52 AM EST, 11/11/2025 (MT Newswires) -- Technology stocks were declining pre-bell Tuesday, with the Technology Select Sector SPDR Fund (XLK) slightly lower and the SPDR S&P Semiconductor ETF (XSD) down 0.5%. Sony Group ( SONY ) stock was up nearly 6% after the company posted higher fiscal Q2 earnings and sales, and raised its fiscal 2025 sales outlook. ...
Tech Sector Under Pressure Amid SoftBank Sale of Nvidia Stake as US Equity Futures Turn Mixed Pre-Bell
Tech Sector Under Pressure Amid SoftBank Sale of Nvidia Stake as US Equity Futures Turn Mixed Pre-Bell
Nov 11, 2025
08:31 AM EST, 11/11/2025 (MT Newswires) -- US equity futures were mixed pre-bell Tuesday, with futures of technology sector-heavy Nasdaq Composite down after Japan's SoftBank Group disclosed it sold its entire $5.83 billion stake in Nvidia ( NVDA ) . Dow Jones Industrial Average futures were 0.1% higher, S&P 500 futures were down 0.2%, and Nasdaq futures were 0.5% lower....
Copyright 2023-2026 - www.financetom.com All Rights Reserved